BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Neptune Technologies & Bioressources Inc.


1/7/2013 10:51:11 AM

NEW YORK, Jan. 7, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, announces that a class action has been filed on behalf of purchasers of the securities of Neptune Technologies & Bioresources Inc. ("Neptune" or the "Company") (Nasdaq CM: NEPT -News), who purchased shared during the period between December 12, 2011 and November 8, 2012, inclusive, (the "Class Period"), concerning whether the company and certain of its officers and directors have violated federal securities laws.

The complaint alleges that, throughout the Class Period, defendants lauded the future benefits of the massive expansion underway at the Company's Sherbrooke production plant the Company's sole production facility which housed all of its inventory. Specifically, the complaint alleges that, during the Class Period, defendants issued materially false and misleading statements regarding the Company's operational status and financial projections, and failed to disclose the following adverse facts: (a) the Company had installed larger acetone storage tanks at the Sherbrooke production plant that facilitated their storing dangerously high levels of acetone that exceeded those permitted by the certificate of authorization issued by the Quebec Ministry of Environment in 2002; (b) the Company had failed to obtain permission from the Quebec government to commence expansion of the Sherbrooke production facility; (c) the Company had been chasing market share at the cost of margins and would see its profit margins collapse by the end of the Class Period; and (d) as a result, the Company was not on track to "maintain [its] operational performances, execute [its] growth strategy, [or to] continue delivering positive results." The trading of Neptune stock was halted following this explosion and upon its resumption on November 27, 2012, it proceeded to close down almost 32% from its closing price prior on the day prior to the explosion.

No Class has yet been certified in the above action. If you wish to review a copy of the Complaint, to discuss this action, or have any questions, please contact either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email eitan@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. February 18, 2013, is the deadline for investors to seek a lead plaintiff appointment.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman, 212-697-6484
eitan@bgandg.com

SOURCE Bronstein, Gewirtz & Grossman, LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES